Medline stock climbs from 52-week low levels

Medline Inc. shares rose nearly 5.0% during morning trading on Tuesday, rebounding from levels close to the stock's 52-week low of $31.49. The company did not release any announcements on the day.

Around 20 Wall Street analysts cover the stock, with most holding Buy-equivalent ratings. The average 12-month price target stands well above current trading levels.

The stock has traded at levels below analyst consensus targets for an extended period.

You May Also Be Interested In

• Texas Capital Securities Starts Porch Group Inc. (PRCH) at Buy
• Worthington Industries (WOR) Tops Q1 EPS by 7c
• UBS Downgrades PG&E Corporation (PCG) to Neutral